Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Gao, Lei  [Clear All Filters]
2014
Gao L, Yu S, Zhang X. Hypothesis: Tim-3/Galectin-9, A New Pathway for Leukemia Stem Cells Survival by Promoting Expansion of Myeloid-Derived Suppressor Cells and Differentiating into Tumor-Associated Macrophages. Cell Biochem Biophys. 2014.
2015
Song N, Gao L, Qiu H, Huang C, Cheng H, Zhou H, Lv S, Chen L, Wang J. Mouse bone marrow-derived mesenchymal stem cells inhibit leukemia/lymphoma cell proliferation in vitro and in a mouse model of allogeneic bone marrow transplant. Int J Mol Med. 2015.
2019
Zhang C, Ma Y-Y, Liu J, Liu Y, Gao L, Gao L, Kong P-Y, Xiong Q-H, Mei W-L, Liu J, et al. Preventive infusion of donor-derived CAR-T cells after haploidentical transplantation: Two cases report. Medicine (Baltimore). 2019;98(29):e16498.
Gao L, Xiang X, Zhang C, Gao L, Yang T, Wang S, Li B, Lou S, Lou S, Liu Y, et al. Upfront autologous hematopoietic stem cell transplantation in patients with high-risk stage III to IV Hodgkin lymphoma: a multicenter retrospective cohort study. Hematology. 2019;24(1):225-231.
2020
Gao L, Zhang Y, Wang S, Kong P, Su Y, Hu J, Jiang M, Bai H, Lang T, Wang J, et al. Effect of rhG-CSF Combined With Decitabine Prophylaxis on Relapse of Patients With High-Risk MRD-Negative AML After HSCT: An Open-Label, Multicenter, Randomized Controlled Trial. J Clin Oncol. 2020:JCO1903277.
Huang T, Yuan S, Gao L, Li M, Yu X, Zhang J, Yin Y, Liu C, Zhang C, Lu G, et al. The histone modification reader ZCWPW1 links histone methylation to PRDM9-induced double strand break repair. Elife. 2020;9.
Chai T, Shen Z, Zhang Z, Chen S, Gao L, Zhang P, Lin W, Kang M, Lin J. LGR6 is a potential diagnostic and prognostic marker for esophageal squamous cell carcinoma. J Clin Lab Anal. 2020:e23121.
Huang A, Zhao X, Li M, Tang G, Fei Y, Wang R, Gao L, Ni X, Zhang W, Yang J, et al. Suppression of hematopoietic primitive cells in patients with secondary failure of platelet recovery after acute graft versus host disease. Biol Blood Marrow Transplant. 2020.
Su R, Dong L, Li Y, Gao M, Han L, Wunderlich M, Deng X, Li H, Huang Y, Gao L, et al. Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion. Cancer Cell. 2020.
2021
Qing Y, Dong L, Gao L, Li C, Li Y, Han L, Prince E, Tan B, Deng X, Wetzel C, et al. R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/mA/PFKP/LDHB axis. Mol Cell. 2021.
2022
Li R, Wang Z, Zhang Y, Guo M, Ni X, Chen J, Chen L, Gao L, Gong S, Tang G, et al. Cytogenetic evolution predicts a poor prognosis in acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2022.
Zhang H, Gao L, Zhang W, Li K. Differentiation of rat bone marrow mesenchymal stem cells into neurons induced by bone morphogenetic protein 7 . Neurol Res. 2022:1-9.
Chao Y, Gao L, Wang X, Cai Y, Shu Y, Zou X, Qin Y, Hu C, Dai Y, Zhu M, et al. Dysregulated adipose tissue expansion and impaired adipogenesis in Prader-Willi syndrome children before obesity-onset. Metabolism. 2022:155295.
Li H, Yu Y, Gao L, Zheng P, Liu X, Chen H. Tissue factor: a neglected role in cancer biology. J Thromb Thrombolysis. 2022.
2023
Feng Y, Chen T, Zhang Y, Yao H, Wang P, Wang L, Cassady K, Zou Z, Liu Y, Zhao L, et al. Azacitidine and lenalidomide combination: a novel relapse prophylaxis regimen after allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia. Front Immunol. 2023;14:1182251.
Wang T, Liu P, Xu L, Gao L, Ni X, Tang G, Chen L, Chen J, Wang L, Wang Y, et al. CEAC (oral semustine, etoposide, cytarabine and cyclophosphamide) vs BEAM (carmustine, etoposide, cytarabine, and melphalan) conditioning regimen of autologous stem cell transplantation for diffuse large B-cell lymphoma: a post-hoc, propensity score-match. Ann Hematol. 2023.
Tan X, Wang X-Q, Zhang C, Zhao X-L, Yao H, Chen G, Ma Y-Y, Wen Q, Gao L, Gao L, et al. Donor-derived CD19 CAR-T Cells versus Chemotherapy Plus Donor Lymphocyte Infusion for Treatment of Recurrent CD19-positive B-ALL After Allogeneic Hematopoietic Stem Cell Transplantation. Curr Med Sci. 2023.
Yao H, Zhang C, Tan X, Li J, Yin X, Deng X, Chen T, Rao J, Gao L, Kong P, et al. Efficacy and toxicity of CLAG combined with pegylated liposomal doxorubicin in the treatment of refractory or relapsed acute myeloid leukemia. Cancer Med. 2023.
Zhu H, Chen J, Liu K, Gao L, Wu H, Ma L, Zhou J, Liu Z, Han J-DJ. Human PBMC scRNA-seq-based aging clocks reveal ribosome to inflammation balance as a single-cell aging hallmark and super longevity. Sci Adv. 2023;9(26):eabq7599.
Guo J, Chen J, Li T, Gao L, Jiang C, Wu W. Integration of transcriptomics, proteomics, and metabolomics data for the detection of the human pathogenic from a One Health perspective. Front Cell Infect Microbiol. 2023;13:1152198.
Huang RH, Chen T, Wang S, Wang J, Su Y, Liu J, Zhang Y, Ma X, Wen Q, Kong P, et al. Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell Transplant: An Open-Label Randomized Clinical Trial. JAMA Oncol. 2023.
Wang L, Kong P, Zhang C, Gao L, Zhu L, Liu J, Gao S, Chen T, Liu H, Yao H, et al. Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-Genzyme. Ann Hematol. 2023.
Ma Y-Y, Wei Z-L, Xu Y-J, Shi J-M, Yi H, Lai Y-R, Jiang E-L, Bin Wang S-, Wu T, Gao L, et al. Poor pretransplantation minimal residual disease clearance as an independent prognostic risk factor for survival in myelodysplastic syndrome with excess blasts: A multicenter, retrospective cohort study. Cancer. 2023.
Zhao Z, Qing Y, Dong L, Han L, Wu D, Li Y, Li W, Xue J, Zhou K, Sun M, et al. QKI shuttles internal mG-modified transcripts into stress granules and modulates mRNA metabolism. Cell. 2023.
Gao L, Sun Y, Zhang X, Ma D, Xie A, Wang E, Cheng L, Liu S. Wnt3a-Loaded Extracellular Vesicles Promote Alveolar Epithelial Regeneration after Lung Injury. Adv Sci (Weinh). 2023:e2206606.

Pages